陕西美邦药业集团股份有限公司关于公司股票交易风险提示公告

Core Viewpoint - The stock of Shaanxi Meibang Pharmaceutical Group Co., Ltd. has experienced significant price fluctuations, with a cumulative increase of over 20% in three consecutive trading days from February 10 to February 12, 2026, leading to a trading anomaly as per Shanghai Stock Exchange regulations [2][3][4]. Group 1: Stock Performance - The stock price increased by 33.10% from a closing price of 21.54 CNY per share on February 10, 2026, to 28.67 CNY per share on February 13, 2026 [2][4]. - The company's latest rolling price-to-earnings (P/E) ratio stands at 130.16, significantly higher than the industry average of 31.99 [4]. Group 2: Business Operations - The company's main business, which includes the research, production, and sales of pesticide products, as well as agricultural technology promotion and services, has not undergone any significant changes [3]. Group 3: Financial Performance - For the first three quarters of 2025, the company reported a revenue of 609 million CNY, reflecting a year-on-year decline of 2.23%. The net profit attributable to shareholders was 36.1961 million CNY, down 16.36% year-on-year [5]. Group 4: Market Sentiment - The company has not identified any media reports or market rumors that could significantly impact its stock price, nor is it involved in any market hot concepts [6].